These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 8395936)
21. Bone marrow transplantation from a pediatric donor with a high frequency of cytomegalovirus-specific T-cells. Komatsu H; Kogawa K; Nonoyama S; Inui A; Sogo T; Fujisawa T; Klenerman P J Med Virol; 2006 Dec; 78(12):1616-23. PubMed ID: 17063516 [TBL] [Abstract][Full Text] [Related]
22. Cognate CD4 T-cell licensing of dendritic cells heralds anti-cytomegalovirus CD8 T-cell immunity after human allogeneic umbilical cord blood transplantation. Flinsenberg TW; Spel L; Jansen M; Koning D; de Haar C; Plantinga M; Scholman R; van Loenen MM; Nierkens S; Boon L; van Baarle D; Heemskerk MH; Boelens JJ; Boes M J Virol; 2015 Jan; 89(2):1058-69. PubMed ID: 25378489 [TBL] [Abstract][Full Text] [Related]
23. Expression of tegument protein pp65 of human cytomegalovirus (CMV) and its application to the analysis of viral-specific cellular immunity in CMV-infected individuals. Tanaka N; Kimura H; Hoshino Y; Nishikawa K; Kojima S; Nishiyama Y; Morishima T Arch Virol; 2002 Dec; 147(12):2405-17. PubMed ID: 12491106 [TBL] [Abstract][Full Text] [Related]
24. Heterogeneity of Specific CD4+ and CD8+ T Cells Stimulated by CMV pp65 and IE1 Antigens. Albiero E; Amati E; Baumeister E; Einsele H; Grigoleit GU; Rodeghiero F J Immunother; 2016; 39(9):329-342. PubMed ID: 27631893 [TBL] [Abstract][Full Text] [Related]
25. Normalizing ELISPOT responses to T-cell counts: a novel approach for quantification of HCMV-specific CD4(+) and CD8(+) T-cell responses in kidney transplant recipients. Calarota SA; Chiesa A; Scaramuzzi L; Adzasehoun KM; Comolli G; Mangione F; Esposito P; Baldanti F J Clin Virol; 2014 Sep; 61(1):65-73. PubMed ID: 24961915 [TBL] [Abstract][Full Text] [Related]
26. Reconstitution of protective immune responses against cytomegalovirus and varicella zoster virus does not require disease development in pediatric recipients of umbilical cord blood transplantation. Merindol N; Salem Fourati I; Brito RM; Grenier AJ; Charrier E; Cordeiro P; Caty M; Mezziani S; Malette B; Duval M; Alfieri C; Ovetchkine P; Le Deist F; Soudeyns H J Immunol; 2012 Nov; 189(10):5016-28. PubMed ID: 23034171 [TBL] [Abstract][Full Text] [Related]
27. Dynamics of CD4 and CD8 T cell responses to cytomegalovirus in healthy human donors. Dunn HS; Haney DJ; Ghanekar SA; Stepick-Biek P; Lewis DB; Maecker HT J Infect Dis; 2002 Jul; 186(1):15-22. PubMed ID: 12089657 [TBL] [Abstract][Full Text] [Related]
28. Reconstitution of CMV pp65 and IE-1-specific IFN-γ CD8(+) and CD4(+) T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT. Tormo N; Solano C; Benet I; Nieto J; de la Cámara R; López J; Garcia-Noblejas A; Muñoz-Cobo B; Costa E; Clari MA; Hernández-Boluda JC; Remigia MJ; Navarro D Bone Marrow Transplant; 2011 Nov; 46(11):1437-43. PubMed ID: 21243030 [TBL] [Abstract][Full Text] [Related]
29. Induction of Thelper1-driven antiviral T-cell lines for adoptive immunotherapy is determined by differential expression of IFN-γ and T-cell activation markers. Leibold J; Feucht J; Halder A; Stevanovic S; Kayser S; Handgretinger R; Feuchtinger T J Immunother; 2012; 35(9):661-9. PubMed ID: 23090075 [TBL] [Abstract][Full Text] [Related]
30. Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure. Nakamura R; Battiwalla M; Solomon S; Follmann D; Chakrabarti S; Cortez K; Hensel N; Childs R; Barrett AJ Biol Blood Marrow Transplant; 2004 Jan; 10(1):49-57. PubMed ID: 14752779 [TBL] [Abstract][Full Text] [Related]
31. Rapid monitoring of immune reconstitution after allogeneic stem cell transplantation--a comparison of different assays for the detection of cytomegalovirus-specific T cells. Abu-Khader A; Krause S Eur J Haematol; 2013 Dec; 91(6):534-45. PubMed ID: 23952609 [TBL] [Abstract][Full Text] [Related]
32. Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease. Krause H; Hebart H; Jahn G; Müller CA; Einsele H Bone Marrow Transplant; 1997 Jun; 19(11):1111-6. PubMed ID: 9193754 [TBL] [Abstract][Full Text] [Related]
33. Co-ordinated isolation of CD8(+) and CD4(+) T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy. Zandvliet ML; van Liempt E; Jedema I; Veltrop-Duits LA; Willemze R; Guchelaar HJ; Falkenburg JH; Meij P Cytotherapy; 2010 Nov; 12(7):933-44. PubMed ID: 20078388 [TBL] [Abstract][Full Text] [Related]
34. Rapid generation of clinical-grade antiviral T cells: selection of suitable T-cell donors and GMP-compliant manufacturing of antiviral T cells. Tischer S; Priesner C; Heuft HG; Goudeva L; Mende W; Barthold M; Kloeß S; Arseniev L; Aleksandrova K; Maecker-Kolhoff B; Blasczyk R; Koehl U; Eiz-Vesper B J Transl Med; 2014 Dec; 12():336. PubMed ID: 25510656 [TBL] [Abstract][Full Text] [Related]
35. Monitoring cytomegalovirus T-cell immunity in small bowel/multivisceral transplant recipients. Chiereghin A; Gabrielli L; Zanfi C; Petrisli E; Lauro A; Piccirilli G; Baccolini F; Dazzi A; Cescon M; Morelli MC; Pinna AD; Landini MP; Lazzarotto T Transplant Proc; 2010; 42(1):69-73. PubMed ID: 20172283 [TBL] [Abstract][Full Text] [Related]